A Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related Diseases

NCT02153398 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Ulcer (GU)
Duodenal Ulcer (DU)
Anastomotic Ulcer (AU)
Non-erosive Reflux Esophagitis Disease (NERD)
Reflux Esophagitis (RE)
Zollinger-Ellison Syndrome

Interventions

DRUG: D961H sachet 10 mg
DRUG: D961H capsule 10mg
DRUG: D961H capsule 20 mg

Sponsor

AstraZeneca